Your browser doesn't support javascript.
loading
Lactobacillus brevis alleviates the progress of hepatocellular carcinoma and type 2 diabetes in mice model via interplay of gut microflora, bile acid and NOTCH 1 signaling.
Chen, Shujia; Han, Ping; Zhang, Qian; Liu, Peiyan; Liu, Jie; Zhao, Lili; Guo, Lianyi; Li, Jia.
Afiliação
  • Chen S; Clinical School of the Second People's Hospital, Tianjin Medical University, Tianjin, China.
  • Han P; Clinical School of the Second People's Hospital, Tianjin Medical University, Tianjin, China.
  • Zhang Q; Clinical School of the Second People's Hospital, Tianjin Medical University, Tianjin, China.
  • Liu P; Clinical School of the Second People's Hospital, Tianjin Medical University, Tianjin, China.
  • Liu J; Department of Hepatology, Tianjin Second People's Hospital, Tianjin, China.
  • Zhao L; Department of Hepatology, Tianjin Second People's Hospital, Tianjin, China.
  • Guo L; Department of Gastroenterology, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
  • Li J; Department of Hepatology, Tianjin Second People's Hospital, Tianjin, China.
Front Immunol ; 14: 1179014, 2023.
Article em En | MEDLINE | ID: mdl-37234174

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Diabetes Mellitus Tipo 2 / Levilactobacillus brevis / Microbioma Gastrointestinal / Neoplasias Hepáticas Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Diabetes Mellitus Tipo 2 / Levilactobacillus brevis / Microbioma Gastrointestinal / Neoplasias Hepáticas Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article